ArticleBMC cancer2020

Study protocol of the HYPER-LIV01 trial: a multicenter phase II, prospective and randomized study comparing simultaneous portal and hepatic vein embolization to portal vein embolization for hypertrophy of the future liver remnant before major hepatectomy for colo-rectal liver metastases.

Emmanuel Deshayes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.